Skip to main content

Table 2 Weight and appendix parameters

From: Evaluation of Juniperus communis L. seed extract on benign prostatic hyperplasia induced in male Wistar rats

Groups

Initial Body weight (g)

Final body weight (g)

Prostate weight (mg)

% inhibition Prostate weight

Prostate index × 10–3

% inhibition prostate index

Normal group (vehicle)

260 ± 8.99

300 ± 3.32

259 ± 4.05

0.866 ± 0.12

Disease group (IM TE injection)

248 ± 2.93*

219 ± 4.25***

359 ± 5.91 ***

1.6419 ± 0.01***

Standard medicine group (TE + finasteride)

239 ± 4.96

260 ± 6.36###

293 ± 4.30###

66.5

1.1127### ± 0.01

68.2033

Group treated with 300 mg/kg JCS extract (TE + 300 mg/kg JCS)

237 ± 5.87#

273 ± 7.12###

320 ± 2.30###

39.4

1.1173### ± 0.01

67.6038

Group treated with 600 mg/kg JCS extract (TE + 600 mg/kg JCS)

267 ± 1.01#

280 ± 2.26###

299 ± 5.26###

60.3

1.1193### ± 0.02

67.3522

  1. Body weight, prostate weight and prostatic index in the examination groups were as follows: normal group (vehicle), disease group, standard medicine group, groups treated with 300 mg/kg and 600 mg/kg JCS extract for 28 days
  2. TE testosterone enanthate, JCS Juniperus communis
  3. The values are expressed as Mean ± SEM (N = 6 animals /group). ***p < 0.001, **p < 0.01, *p < 0.05 vs Control, ###p < 0.001, ##p < 0.01 and #p < 0.05 vs TE group